Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Teva Buys U.S. Generic Drugmaker
10:24 AM MDT | August 4, 2008 | Deepti Ramesh
Teva Pharmaceutical Industries Ltd. (Petach Tikva, Israel) says it has completed the acquisition of Bentley Pharmaceuticals (Exeter, NH) for about $360 million. Bentley produces generic pharmaceuticals, which generated revenues of about $114 million in 2007. Teva expects the acquisition to become accretive to earnings within 12 months. Bentley spun off a drug delivery business to shareholders in June and currently manufactures and markets about 130 pharma products, as well as active pharmaceutical ingredients (APIs) through its subsidiary Bentley API. The...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee